The Prognostic Value of Heart-type Fatty Acid Binding Protein in Patients with Acute Coronary Syndrome. | [Journal of College of Physicians and Surgeons--Pakistan : JCPSP • 2018]

Author(s):

1. Wang HaiLong: Department of Cardiology, Chongqing Three Gorges Central Hospital, Chongqing, China

2. Pang XiaoHua: Department of Cardiology, Chongqing Three Gorges Central Hospital, Chongqing, China

3. Yang JianJun: Department of Cardiology, Chongqing Three Gorges Central Hospital, Chongqing, China

4. Tu XueMei: Department of Cardiology, Chongqing Three Gorges Central Hospital, Chongqing, China

Abstract:

The effect of heart-type fatty acid binding protein (H-FABP) remains unclear on the quality of the prognoses of patients with acute coronary syndrome (ACS). The authors searched the EMBASE, PubMed, Cochrane Library, and Medline electronic databases from their respective inceptions throughout June 2017. Odds ratios were pooled from individual studies, and conducted heterogeneity analysis, quality assessment, and publication bias analysis. A total of four studies with 1,994 patients were included (554 positive patients; 1,440 negative patients). Pooled analysis of these studies showed that patients positive for H-FABP had higher incidence for mortality (OR, 6.39; p<0.01) and cardiac events (OR, 3.94; P<0.01) than negative patients, but myocardial infarction (MI) (OR, 1.43; P=0.32) showed no significant differences. ACS patients positive for H-FABP had higher rates in cardiac events and mortality. The incidence of MI showed no significant difference, possibly because this study was based on limited data from randomized studies. Additional substantial randomized controlled trials certainly needed to verify these discovery.

Page(s): 56-60

DOI: DOI not available

Published: Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 1, Year: 2018

Keywords:

Keywords are not available for this article.

References:

[1] AndersonJL,AdamsCD,AntmanEM, 2007.AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine,J Am Coll Cardiol 50 e1 -157

[2] D'Ascenzo,F , Biondi-Zoccai,G , Moretti,C, 2012.TIMI, GRACE and alternative risk scores in acute coronary syndromes: a metaanalysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients,Contemp Clin Trials 33 507 -14

[3] StorchJ,ThumserAE, 2000.The fatty acid transport function of fatty acid-binding proteins,Biochim Biophys Acta 1486 28 -44

[4] GlatzJF,vanBM,PaulussenRJ,VeerkampJH,Van der VusseGJ,RenemanRS, 1988.Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox,Biochim Biophys Acta 961 148 -52

[5] WideraC,PencinaMJ,MeisnerA, 2012.Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome,Eur Heart J 33 1095 -104

[6] EggersKM,KempfT,VengeP,WallentinL,WollertKC,LindahlB, 2010.Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers,Am Heart J 160 88 -94

[7] KilcullenN,ViswanathanK,DasR, 2007.Heart-type fatty acid binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values,J Am Coll Cardiol 50 2061 -7

[8] SuzukiM,HoriS,NomaS,KobayashiK., 2005.Prognostic value of a qualitative test for heart-type fatty acid-binding protein in patients with acute coronary syndrome,Int Heart J 40 601 -6

[9] IshiiJ,OzakiY,LuJ, 2005.Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome,Clinical Chemistry 51 1397 -1404

[10] IlvaTuomo,PorelaPekka, 2009.Early markers of myocardial injury: cTnI is enough,Clinica Chimica Acta 400 82 -5

[11] MatsumotoS,NakataniD,SakataY., 2013.Elevated serum hearttype fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction,Circulation J 77 1026 -32

[12] LiberatiA,AltmanDG,TetzlaffJ, 2009.The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration,J Clin Epidemiol 62 e1 -34

[13] HigginsJP, 2011.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials,BMJ 343 d5928 -

[14] HigginsJP, 2003.Measuring inconsistency in meta-analyses,BMJ 327 557 -60

[15] BodyR,CarleyS,McDowellG, 2014.The Manchester Acute Coronary Syndromes (MACS) decision rule for suspected cardiac chest pain: derivation and external validation,Heart 100 1462 -8

[16] VasanRS, 2006.Biomarkers of cardiovascular disease: molecular basis and practical considerations,Circulation 113 2335 -62

Citations

Downloads

Views